Clinical Cancer Research Versailles No Abst Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jalili, A.
Right arrow Articles by Golab, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jalili, A.
Right arrow Articles by Golab, J.
Clinical Cancer Research Vol. 10, 4498-4508, July 1, 2004
© 2004 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells

Ahmad Jalili1, Marcin Makowski1, Tomasz Switaj1, Dominika Nowis1, Grzegorz M. Wilczynski3, Ewa Wilczek3, Magdalena Chorazy-Massalska4, Anna Radzikowska4, Wlodzimierz Maslinski4, Lukasz Bialy2, Jacek Sienko5, Aleksander Sieron6, Mariusz Adamek6, Grzegorz Basak1, Pawel Mróz1, Ireneusz W. Krasnodebski7, Marek Jakóbisiak1 and Jakub Golab1

Departments of 1 Immunology, 2 Histology and Embryology, and 3 Pathology, Center of Biostructure Research, The Medical University of Warsaw, Warsaw; 4 Department of Pathophysiology and Immunology, Institute of Rheumatology, Warsaw, 5 II Department and Clinic of Obstetrics and Gynecology, The Medical University of Warsaw, Warsaw; 6 Center for Laser Diagnostics and Therapy, Chair and Clinic of Internal Diseases and Physical Medicine, Silesian Medical University, Bytom; and 7 Department of General, Gastrointestinal Surgery and Nutrition, The Medical University of Warsaw, Warsaw, Poland

Purpose: The unique mechanism of tumor destruction by photodynamic therapy (PDT), resulting from apoptotic and necrotic killing of tumor cells accompanied by local inflammatory reaction and induction of heat shock proteins (HSPs), prompted us to investigate the antitumor effectiveness of the combination of PDT with administration of immature dendritic cells (DCs).

Experimental Design: Confocal microscopy and Western blotting were used to investigate the influence of PDT on the induction of apoptosis and expression of HSP expression in C-26 cells. Confocal microscopy and flow cytometry studies were used to examine phagocytosis of PDT-treated C-26 cells by DCs. Secretion of interleukin (IL)-12 was measured with ELISA. Cytotoxic activity of lymph node cells was evaluated in a standard 51Cr-release assay. The antitumor effectiveness of PDT in combination with administration of DCs was investigated in in vivo model.

Results: PDT treatment resulted in the induction of apoptotic and necrotic cell death and expression of HSP27, HSP60, HSP72/73, HSP90, HO-1, and GRP78 in C-26 cells. Immature DCs cocultured with PDT-treated C-26 cells efficiently engulfed killed tumor cells, acquired functional features of maturation, and produced substantial amounts of IL-12. Inoculation of immature DCs into the PDT-treated tumors resulted in effective homing to regional and peripheral lymph nodes and stimulation of cytotoxic activity of T and natural killer cells. The combination treatment with PDT and administration of DCs produced effective antitumor response.

Conclusions: The feasibility and antitumor effectiveness demonstrated in these studies suggest that treatment protocols involving the administration of immature DCs in combination with PDT may have clinical potential.




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Szokalska, M. Makowski, D. Nowis, G. M. Wilczynski, M. Kujawa, C. Wojcik, I. Mlynarczuk-Bialy, P. Salwa, J. Bil, S. Janowska, et al.
Proteasome Inhibition Potentiates Antitumor Effects of Photodynamic Therapy in Mice through Induction of Endoplasmic Reticulum Stress and Unfolded Protein Response
Cancer Res., May 15, 2009; 69(10): 4235 - 4243.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. Triesscheijn, P. Baas, J. H. M. Schellens, and F. A. Stewart
Photodynamic Therapy in Oncology
Oncologist, October 1, 2006; 11(9): 1034 - 1044.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Saji, W. Song, K. Furumoto, H. Kato, and E. G. Engleman
Systemic Antitumor Effect of Intratumoral Injection of Dendritic Cells in Combination with Local Photodynamic Therapy
Clin. Cancer Res., April 15, 2006; 12(8): 2568 - 2574.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.